Patent · US Active

Substituted diazaspiroalkanes as androgen receptor modulators

US11771687B2 · kind B2 · utility

0Cited by

61References

28Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Michael E. Jung · Los Angeles, US
Charles L. Sawyers · New York, US
Samedy Ouk · San Diego, US
Chris Tran · New York, US
John Wongvipat · Nanuet, US

Key dates

Filing date	Nov 9, 2020
Grant date	Oct 3, 2023
Priority date	—
Expiry date	May 28, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are hydantoin compounds useful for the prevention or treatment of hyperproliferative diseases or disorders. Exemplary hydantoin compounds include substituted diazaspiroalkanes, such as (A51) and (A52) having the following structures:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.